379 related articles for article (PubMed ID: 23076159)
1. Extracellular assembly and activation principles of oncogenic class III receptor tyrosine kinases.
Verstraete K; Savvides SN
Nat Rev Cancer; 2012 Nov; 12(11):753-66. PubMed ID: 23076159
[TBL] [Abstract][Full Text] [Related]
2. Receptor tyrosine kinases in normal and malignant haematopoiesis.
Reilly JT
Blood Rev; 2003 Dec; 17(4):241-8. PubMed ID: 14556779
[TBL] [Abstract][Full Text] [Related]
3. New insights into the mechanisms of hematopoietic cell transformation by activated receptor tyrosine kinases.
Toffalini F; Demoulin JB
Blood; 2010 Oct; 116(14):2429-37. PubMed ID: 20581310
[TBL] [Abstract][Full Text] [Related]
4. Receptor tyrosine kinases: from biology to pathology.
Choura M; Rebaï A
J Recept Signal Transduct Res; 2011 Dec; 31(6):387-94. PubMed ID: 22040163
[TBL] [Abstract][Full Text] [Related]
5. A functional RNAi screen for regulators of receptor tyrosine kinase and ERK signalling.
Friedman A; Perrimon N
Nature; 2006 Nov; 444(7116):230-4. PubMed ID: 17086199
[TBL] [Abstract][Full Text] [Related]
6. Feedback regulation of RTK signaling in development.
Neben CL; Lo M; Jura N; Klein OD
Dev Biol; 2019 Mar; 447(1):71-89. PubMed ID: 29079424
[TBL] [Abstract][Full Text] [Related]
7. Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development.
Annenkov A
Mol Neurobiol; 2014 Feb; 49(1):440-71. PubMed ID: 23982746
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic receptors of class III receptor-type tyrosine kinases.
Rosnet O; Birnbaum D
Crit Rev Oncog; 1993; 4(6):595-613. PubMed ID: 7506935
[TBL] [Abstract][Full Text] [Related]
9. Receptor Tyrosine Kinases: Translocation Partners in Hematopoietic Disorders.
Nelson KN; Peiris MN; Meyer AN; Siari A; Donoghue DJ
Trends Mol Med; 2017 Jan; 23(1):59-79. PubMed ID: 27988109
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine kinase receptors as attractive targets of cancer therapy.
Bennasroune A; Gardin A; Aunis D; Crémel G; Hubert P
Crit Rev Oncol Hematol; 2004 Apr; 50(1):23-38. PubMed ID: 15094157
[TBL] [Abstract][Full Text] [Related]
11. Receptor tyrosine kinases and their activation in melanoma.
Easty DJ; Gray SG; O'Byrne KJ; O'Donnell D; Bennett DC
Pigment Cell Melanoma Res; 2011 Jun; 24(3):446-61. PubMed ID: 21320293
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of RTK signaling.
Spangle JM; Roberts TM
J Mol Med (Berl); 2017 Aug; 95(8):791-798. PubMed ID: 28589435
[TBL] [Abstract][Full Text] [Related]
13. Receptor tyrosine kinases are signaling intermediates of G protein-coupled receptors.
Piiper A; Zeuzem S
Curr Pharm Des; 2004; 10(28):3539-45. PubMed ID: 15579051
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic lymphoma kinase: "Ligand Independent Activation" mediated by the PTN/RPTPβ/ζ signaling pathway.
Deuel TF
Biochim Biophys Acta; 2013 Oct; 1834(10):2219-23. PubMed ID: 23777859
[TBL] [Abstract][Full Text] [Related]
15. Origin and molecular evolution of receptor tyrosine kinases with immunoglobulin-like domains.
Grassot J; Gouy M; Perrière G; Mouchiroud G
Mol Biol Evol; 2006 Jun; 23(6):1232-41. PubMed ID: 16551648
[TBL] [Abstract][Full Text] [Related]
16. Breaking Oncogene Addiction: Getting RTK/RAS-Mutated Cancers off the SOS.
Sheffels E; Kortum RL
J Med Chem; 2021 May; 64(10):6566-6568. PubMed ID: 33961431
[TBL] [Abstract][Full Text] [Related]
17. The transition model of RTK activation: A quantitative framework for understanding RTK signaling and RTK modulator activity.
Paul MD; Hristova K
Cytokine Growth Factor Rev; 2019 Oct; 49():23-31. PubMed ID: 31711797
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the landscape of gene cooperativity with receptor tyrosine kinases in liver tumorigenesis using transposon-mediated mutagenesis.
Fan Y; Bazai SK; Daian F; Arechederra M; Richelme S; Temiz NA; Yim A; Habermann BH; Dono R; Largaespada DA; Maina F
J Hepatol; 2019 Mar; 70(3):470-482. PubMed ID: 30529386
[TBL] [Abstract][Full Text] [Related]
19. Rare SNPs in receptor tyrosine kinases are negative outcome predictors in multiple myeloma.
Keppler S; Weiβbach S; Langer C; Knop S; Pischimarov J; Kull M; Stühmer T; Steinbrunn T; Bargou R; Einsele H; Rosenwald A; Leich E
Oncotarget; 2016 Jun; 7(25):38762-38774. PubMed ID: 27246973
[TBL] [Abstract][Full Text] [Related]
20. Cell signaling by receptor tyrosine kinases.
Lemmon MA; Schlessinger J
Cell; 2010 Jun; 141(7):1117-34. PubMed ID: 20602996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]